Assignee
INTERVET INC
US·202 granted patents·149 pending applications·349 citations·filing 1980–2025
Top patents by PatentIndex Score
351 records- 0195US10106607B2Caninized antibodiesINTERVET INC·Filed 2014·Granted Oct 23, 2018·22 cites·14 claims
- 0294US9532978B2Topical localized isoxazoline formulationINTERVET INC·Filed 2015·Granted Jan 3, 2017·13 cites·10 claims
- 0393US11285101B2Soft chewable pharmaceutical productsINTERVET INC·Filed 2019·Granted Mar 29, 2022·6 cites·26 claims
- 0493US10751403B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2019·Granted Aug 25, 2020·6 cites·13 claims
- 0592US9944704B2Antibodies against canine PD-1INTERVET INC·Filed 2014·Granted Apr 17, 2018·8 cites·5 claims
- 0691US12128032B2Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultryINTERVET INC·Filed 2022·Granted Oct 29, 2024·1 cites·5 claims
- 0791US11680097B2Antibodies against canine PD-1INTERVET INC·Filed 2020·Granted Jun 20, 2023·2 cites·10 claims
- 0891US11229698B2Recombinant non-pathogenic Marek's Disease virus constructs encoding multiple heterologous antigensINTERVET INC·Filed 2018·Granted Jan 25, 2022·5 cites·20 claims
- 0989US11167021B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2018·Granted Nov 9, 2021·3 cites·6 claims
- 1089US11103569B2Vaccine for protection against Streptococcus suisINTERVET INC·Filed 2018·Granted Aug 31, 2021·3 cites·5 claims
- 1189US10863727B2Method for automatic sea lice monitoring in salmon aquacultureINTERVET INC·Filed 2016·Granted Dec 15, 2020·12 cites·18 claims
- 1289US10653675B2Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultryINTERVET INC·Filed 2019·Granted May 19, 2020·4 cites·25 claims
- 1389US10023636B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2014·Granted Jul 17, 2018·5 cites·4 claims
- 1489US8044102B2Compositions and method for treating infection in cattle and swineINTERVET INC·Filed 2005·Granted Oct 25, 2011·16 cites·1 claims
- 1588US11337917B2Soft chewable pharmaceutical productsINTERVET INC·Filed 2017·Granted May 24, 2022·4 cites·19 claims
- 1688US11248047B2Caninized antibodiesINTERVET INC·Filed 2018·Granted Feb 15, 2022·2 cites·16 claims
- 1788US11229699B2Feline calicivirus vaccineINTERVET INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 1888US10864195B2Topical localized isoxazoline formulationINTERVET INC·Filed 2017·Granted Dec 15, 2020·3 cites·15 claims
- 1988US9314519B2Liquid stable virus vaccinesINTERVET INC·Filed 2013·Granted Apr 19, 2016·7 cites·21 claims
- 2087US12383610B2Vaccine for protection against Streptococcus suis serotype 9, sequence type 16INTERVET INC·Filed 2021·Granted Aug 12, 2025·1 cites·14 claims
- 2187US11311616B2Feline leukemia virus vaccineINTERVET INC·Filed 2018·Granted Apr 26, 2022·2 cites·20 claims
- 2287US10973759B2Manufacturing of semi-plastic pharmaceutical dosage unitsINTERVET INC·Filed 2019·Granted Apr 13, 2021·3 cites·13 claims
- 2387US10927172B2Caninized murine antibodies to human PD-1INTERVET INC·Filed 2018·Granted Feb 23, 2021·2 cites·10 claims
- 2487US10711061B2Antibodies against canine PD-1INTERVET INC·Filed 2018·Granted Jul 14, 2020·2 cites·17 claims
- 2587US9599607B2Potency test for vaccine formulationsINTERVET INC·Filed 2014·Granted Mar 21, 2017·5 cites·29 claims
- 2686US11883530B2Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animalsINTERVET INC·Filed 2021·Granted Jan 30, 2024·1 cites·12 claims
- 2786US11167027B2Multivalent feline vaccineINTERVET INC·Filed 2018·Granted Nov 9, 2021·2 cites·20 claims
- 2886US11034650B2Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infectionINTERVET INC·Filed 2017·Granted Jun 15, 2021·2 cites·4 claims
- 2986US7732187B2Recombinant attenuated clostridium organisms and vaccineINTERVET INC·Filed 2007·Granted Jun 8, 2010·9 cites·29 claims
- 3086US7713950B2Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereofINTERVET INC·Filed 2008·Granted May 11, 2010·8 cites·4 claims
- 3186US2023320981A1Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2023·Application pending·0 cites
- 3285US11447561B2PD-L1 antibodies binding canine PD-L1INTERVET INC·Filed 2019·Granted Sep 20, 2022·2 cites·12 claims
- 3385US11406617B2Compounds for the treatment of bovine or swine respiratory diseaseINTERVET INC·Filed 2017·Granted Aug 9, 2022·2 cites·2 claims
- 3485US8932604B2Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigensINTERVET INC·Filed 2012·Granted Jan 13, 2015·10 cites·23 claims
- 3585US2024084004A1Antibodies against canine pd-1INTERVET INC·Filed 2023·Application pending·0 cites
- 3684US11548859B2Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acidINTERVET INC·Filed 2019·Granted Jan 10, 2023·2 cites·15 claims
- 3784US11530187B2Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acidINTERVET INC·Filed 2019·Granted Dec 20, 2022·2 cites·16 claims
- 3884US11179372B2Isoxazoline solution containing vitamin E for use with sanitized drinking waterINTERVET INC·Filed 2019·Granted Nov 23, 2021·2 cites·2 claims
- 3984US9827305B2Poultry virus vaccines that are liquid stableINTERVET INC·Filed 2015·Granted Nov 28, 2017·5 cites·23 claims
- 4084US9770440B2Solid oral pharmaceutical compositions for isoxazoline compoundsINTERVET INC·Filed 2013·Granted Sep 26, 2017·5 cites·18 claims
- 4184US9393298B2Liquid stable bovine virus vaccinesINTERVET INC·Filed 2014·Granted Jul 19, 2016·10 cites·22 claims
- 4284US8034845B2Compositions and method for treating infection in cattle and swineINTERVET INC·Filed 2004·Granted Oct 11, 2011·22 cites·5 claims
- 4384US7786329B2Process for preparing ester oxazolidine compounds and their conversion to FlorfenicolINTERVET INC·Filed 2006·Granted Aug 31, 2010·8 cites·85 claims
- 4483US10117839B2Encapsulation of hydrophobic biologically active compoundsINTERVET INC·Filed 2015·Granted Nov 6, 2018·4 cites·18 claims
- 4583US9409954B2Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigensINTERVET INC·Filed 2014·Granted Aug 9, 2016·7 cites·21 claims
- 4683US2024398934A1Feline leukemia virus vaccineINTERVET INC·Filed 2024·Application pending·0 cites
- 4783US2024239759A1Isoxazoline compositions and their use as antiparasiticsINTERVET INC·Filed 2024·Application pending·0 cites
- 4882US10875847B2Aminopyrazoles as selective janus kinase inhibitorsINTERVET INC·Filed 2017·Granted Dec 29, 2020·2 cites·18 claims
- 4982US2025179199A1Antibodies to canine interleukin-4 receptor alphaINTERVET INC·Filed 2024·Application pending·0 cites
- 5081US12252536B2Caninized antibodiesINTERVET INC·Filed 2022·Granted Mar 18, 2025·0 cites·13 claims
Showing the top 50 of 351 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when INTERVET INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →